Linwei Wu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hepatology 17
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Liver physiology and pathology 3
- Surgery 35
- Organ Transplantation Techniques and Outcomes 33
- Transplantation: Methods and Outcomes 3
- Co-authors
- Xiao-Shun He (32 shared papers)Weiqiang Ju (26 shared papers)Zhiyong Guo (19 shared papers)Dongping Wang (22 shared papers)Yushu Shang (3 shared papers)Paul Michael Schroder (4 shared papers)Wenhua Liang (3 shared papers)Nga Lei Tam (8 shared papers)
- Journals
- PLoS ONE (5 papers)Scientific Reports (2 papers)American Journal of Transplantation (2 papers)Cancer Cell (2 papers)Molecular Carcinogenesis (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Linwei Wu
69 papers receiving 1.9k citations
Linwei Wu's Hit Papers
Peers
Comparison fields: 5 of 78
- Hepatology 348
- Transplantation 117
- Cancer Research 278
- Surgery 620
- Molecular Biology 410
Countries citing papers authored by Linwei Wu
This map shows the geographic impact of Linwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linwei Wu more than expected).
Fields of papers citing papers by Linwei Wu
This network shows the impact of papers produced by Linwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linwei Wu. The network helps show where Linwei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linwei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 209 | |
| 2 | 2014 | 168 | |
| 3 | 2016 | 133 | |
| 4 | 2017 | 129 | |
| 5 | A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease Hit paper breakdown → | 2023 | 88 |
| 6 | 2012 | 81 | |
| 7 | 2012 | 80 | |
| 8 | 2012 | 68 | |
| 9 | 2013 | 52 | |
| 10 | 2016 | 50 | |
| 11 | 2015 | 48 | |
| 12 | 2021 | 40 | |
| 13 | 2014 | 35 | |
| 14 | 2014 | 35 | |
| 15 | 2014 | 35 | |
| 16 | 2018 | 34 | |
| 17 | 2020 | 32 | |
| 18 | 2018 | 31 | |
| 19 | 2019 | 30 | |
| 20 | 2018 | 29 |
About Linwei Wu
Linwei Wu is a scholar working on Hepatology, Surgery, Transplantation, Cancer Research and Oncology, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (33 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Renal Transplantation Outcomes and Treatments (7 papers), Cancer Immunotherapy and Biomarkers (3 papers), Transplantation: Methods and Outcomes (3 papers), Liver physiology and pathology (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Hepatology (348 citations), Transplantation (117 citations), Cancer Research (278 citations), Surgery (620 citations) and Molecular Biology (410 citations). Linwei Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiao-Shun He, Weiqiang Ju, Zhiyong Guo, Dongping Wang, Yushu Shang, Paul Michael Schroder, Wenhua Liang, Nga Lei Tam, Xiaoting Ling and Ronghai Deng. Their work appears in journals such as PLoS ONE, Scientific Reports, American Journal of Transplantation, Cancer Cell and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.